{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:03:06Z","timestamp":1769025786817,"version":"3.49.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/spc.0000000000000061","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T12:36:10Z","timestamp":1402058170000},"page":"279-285","source":"Crossref","is-referenced-by-count":12,"title":["The assessment and management of cancer cachexia"],"prefix":"10.1097","volume":"8","author":[{"given":"Rony","family":"Dev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20211004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0936-6555(03)00155-9","article-title":"Nutritional deterioration in cancer: the role of disease and diet.","volume":"15","author":"Ravasco","year":"2003","journal-title":"Clin Oncol"},{"key":"R2-17-20211004","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s005200050282","article-title":"Cachexia and anorexia: cancers covert killer.","volume":"8","author":"Davis","year":"2000","journal-title":"Support Care Cancer"},{"key":"R3-17-20211004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus.","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R4-17-20211004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MCO.0b013e3283025e27","article-title":"Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue.","volume":"11","author":"Strasser","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R6-17-20211004","first-page":"233","article-title":"Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis.","volume":"6","author":"McGeer","year":"1990","journal-title":"Nutrition"},{"key":"R7-17-20211004","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI112749","article-title":"Determinants of 24-h energy expenditure in man: methods and results using respiratory chamber.","volume":"78","author":"Ravussin","year":"1986","journal-title":"J Clin Invest"},{"key":"R8-17-20211004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ajcn\/61.1.4","article-title":"Influence of body composition and resting metabolic rate on variation in total energy expenditure: a meta-analysis.","volume":"61","author":"Carpenter","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"R10-17-20211004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/ajcn\/69.3.461","article-title":"Comparison of indirect calorimetry, the Fick method, and prediction equations in estimating the energy requirements of critically ill patients.","volume":"69","author":"Flancbaum","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R11-17-20211004","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajcn\/42.6.1170","article-title":"Human energy requirements: overestimation by widely used prediction equation.","volume":"42","author":"Daly","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"R12-17-20211004","first-page":"32","article-title":"The agreement between measured and predicted resting energy expenditure in patients with pancreatic cancer: a pilot study.","volume":"5","author":"Bauer","year":"2004","journal-title":"J Pancreas"},{"key":"R13-17-20211004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000658-198302000-00006","article-title":"Energy expenditure in malnourished cancer patients.","volume":"197","author":"Knox","year":"1983","journal-title":"Ann Surg"},{"key":"R14-17-20211004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients.","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int J Cancer"},{"key":"R15-17-20211004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0277-5379(91)90050-N","article-title":"Elevated energy expenditure in cancer patients with solid tumours.","volume":"27","author":"Hyltander","year":"1991","journal-title":"Eur J Cancer"},{"key":"R16-17-20211004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nut.2006.03.006","article-title":"Resting energy expenditure in patients with solid tumor undergoing anticancer therapy.","volume":"22","author":"Reeves","year":"2006","journal-title":"Nutrition"},{"key":"R17-17-20211004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clnu.2009.07.001","article-title":"Resting energy expenditure and body composition in patients with newly detected cancer.","volume":"29","author":"Cao","year":"2010","journal-title":"Clin Nutr"},{"key":"R18-17-20211004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.urolonc.2010.07.017","article-title":"Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients.","volume":"30","author":"Xu","year":"2012","journal-title":"Urol Oncol"},{"key":"R19-17-20211004","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/1097-0142(19840315)53:6<1265::AID-CNCR2820530609>3.0.CO;2-2","article-title":"Energy expenditure in malnourished gastrointestinal cancer patients.","volume":"53","author":"Dempsey","year":"1984","journal-title":"Cancer"},{"key":"R20-17-20211004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/07357900701208873","article-title":"Colorectal cancer: intrinsic characteristics modulate cancer energy expenditure and the risk of cachexia.","volume":"25","author":"Ravasco","year":"2007","journal-title":"Cancer Invest"},{"key":"R21-17-20211004","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/ajcn\/53.5.1318","article-title":"Resting energy expenditure in patients with newly detected gastric and colorectal cancers.","volume":"53","author":"Fredrix","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"R22-17-20211004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0148607190014002119","article-title":"Resting metabolic rate of esophageal carcinoma patients: a model for energy expenditure measurement in a homogenous cancer population.","volume":"14","author":"Thompson","year":"1990","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R23-17-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3164\/jcbn.11-13","article-title":"Resting energy expenditure and nutritional status in patients undergoing transthoracic esophagectomy for esophageal cancer.","volume":"49","author":"Okamoto","year":"2011","journal-title":"J Clin Biochem Nutr"},{"key":"R24-17-20211004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12149-010-0456-9","article-title":"Positive correlations between tumor uptake on FDG PET and energy expenditure of patients with esophageal cancer.","volume":"25","author":"Mitumura","year":"2011","journal-title":"Ann Nucl Med"},{"key":"R25-17-20211004","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.nut.2013.04.010","article-title":"Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer.","volume":"29","author":"Wu","year":"2013","journal-title":"Nutrition"},{"key":"R26-17-20211004","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann Surg"},{"key":"R27-17-20211004","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MPA.0b013e3182264d05","article-title":"Effect of tumor load on energy expenditure in, patients with pancreatic cancer.","volume":"41","author":"Vaisman","year":"2012","journal-title":"Pancreas"},{"key":"R28-17-20211004","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.52.4.338","article-title":"Metabolism in patients with small cell lung carcinoma compared with patients with nonsmall cell lung carcinoma and healthy controls.","volume":"52","author":"Staal-van Brekel","year":"1997","journal-title":"Thorax"},{"key":"R29-17-20211004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0003-4975(01)02847-8","article-title":"Do patients with nonmetastatic nonsmall cell lung cancer demonstrate altered resting energy expenditure.","volume":"72","author":"Jatoi","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R30-17-20211004","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<717::AID-CNCR8>3.0.CO;2-A","article-title":"Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors.","volume":"79","author":"Fredrix","year":"1997","journal-title":"Cancer"},{"key":"R31-17-20211004","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.nut.2005.03.006","article-title":"Prospective study of resting energy expenditure changes in head and neck cancer patients treated with chemoradiotherapy measured by indirect calorimetry.","volume":"21","author":"Garcia-Peris","year":"2005","journal-title":"Nutrition"},{"key":"R32-17-20211004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hed.20607","article-title":"Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy.","volume":"29","author":"Silver","year":"2007","journal-title":"Head Neck"},{"key":"R33-17-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1207\/s15327914nc4902_6","article-title":"Nutritional consequences of radiotherapy in nasopharynx cancer patients.","volume":"49","author":"Ng","year":"2004","journal-title":"Nutr Cancer"},{"key":"R34-17-20211004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clnu.2011.12.009","article-title":"Resting energy expenditure in head and neck cancer patients before and during radiotherapy.","volume":"31","author":"Langius","year":"2012","journal-title":"Clin Nutr"},{"key":"R35-17-20211004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjc.1995.300","article-title":"Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients.","volume":"72","author":"Wigmore","year":"1995","journal-title":"Br J Cancer"},{"key":"R37-17-20211004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS19990273","article-title":"Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.","volume":"98","author":"Barber","year":"2000","journal-title":"Clin Sci"},{"key":"R38-17-20211004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0026-0495(99)90074-4","article-title":"Intralipid infusion combined with propranolol administration has favorable effects in elderly malnourished cancer patients.","volume":"48","author":"Gambardella","year":"1999","journal-title":"Metabolism"},{"key":"R39-17-20211004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia.","volume":"88","author":"Mantovani","year":"2010","journal-title":"J Mol Med"},{"key":"R40-17-20211004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life.","volume":"124","author":"Mantovani","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R41-17-20211004","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.ejcn.1602114","article-title":"Clinical accuracy of the MedGem indirect calorimeter for measuring resting energy expenditure in cancer patients.","volume":"59","author":"Reeves","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"R42-17-20211004","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/cncr.22339","article-title":"The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.","volume":"107","author":"Strasser","year":"2006","journal-title":"Cancer"},{"key":"R44-17-20211004","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"R45-17-20211004","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13685530500361226","article-title":"The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer.","volume":"8","author":"Boxer","year":"2005","journal-title":"Aging Male"},{"key":"R46-17-20211004","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/jcem-56-6-1278","article-title":"Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.","volume":"56","author":"Bremner","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-17-20211004","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2009.09.021","article-title":"Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report.","volume":"39","author":"Del Fabbro","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"R48-17-20211004","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/cncr.21889","article-title":"Hypogonadism in male patients with cancer.","volume":"106","author":"Garcia","year":"2006","journal-title":"Cancer"},{"key":"R49-17-20211004","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0885-3924(03)00331-2","article-title":"Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy.","volume":"26","author":"Rajagopal","year":"2003","journal-title":"J Pain Symptom Manag"},{"key":"R50-17-20211004","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cancer and relationship with cachexia.","volume":"97","author":"Burney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-17-20211004","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/cncr.28619","article-title":"Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer.","volume":"120","author":"Dev","year":"2014","journal-title":"Cancer"},{"key":"R52-17-20211004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00520-010-0832-y","article-title":"Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.","volume":"19","author":"Skipworth","year":"2011","journal-title":"Support Care Cancer"},{"key":"R53-17-20211004","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(10)70021-8","article-title":"Male hypogonadism associated with advanced cancer: a systematic review.","volume":"11","author":"Vigano","year":"2010","journal-title":"Lancet Oncol"},{"key":"R54-17-20211004","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline.","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-17-20211004","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00520-013-1832-5","article-title":"Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial.","volume":"21","author":"Del Fabbro","year":"2013","journal-title":"Support Care Cancer"},{"key":"R56-17-20211004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men.","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201409000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T13:53:08Z","timestamp":1633528388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201409000-00017"}},"subtitle":["hypogonadism and hypermetabolism among supportive and palliative care patients"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000061","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}